News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
881,173 Results
Type
Article (88633)
Company Profile (817)
Press Release (791692)
Multimedia
Podcasts (230)
Webinars (34)
Section
Business (233528)
Career Advice (4159)
Deals (39956)
Drug Delivery (172)
Drug Development (91632)
Employer Resources (207)
FDA (18530)
Job Trends (17475)
News (398577)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3045)
Academic (2)
Accelerated approval (50)
Adcomms (39)
Allergies (185)
Alliances (56987)
ALS (225)
Alzheimer's disease (1947)
Antibody-drug conjugate (ADC) (502)
Approvals (18821)
Artificial intelligence (822)
Autoimmune disease (320)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (487)
Bladder cancer (203)
Brain cancer (81)
Breast cancer (798)
Cancer (6207)
Cardiovascular disease (529)
Career advice (3591)
Career pathing (49)
CAR-T (366)
CDC (75)
Celiac Disease (3)
Cell therapy (1025)
Cervical cancer (49)
Clinical research (78497)
Collaboration (2264)
Company closure (8)
Compensation (1440)
Complete response letters (103)
COVID-19 (3030)
CRISPR (119)
C-suite (1205)
Cystic fibrosis (164)
Data (8112)
Decentralized trials (3)
Denatured (87)
Depression (188)
Dermatology (89)
Diabetes (636)
Diagnostics (7519)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (397)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (305)
Earnings (102402)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137708)
Executive appointments (1163)
FDA (22427)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (35)
Funding (1860)
Gene editing (263)
Generative AI (87)
Gene therapy (832)
GLP-1 (1249)
Government (5545)
Grass and pollen (8)
Guidances (413)
Healthcare (21099)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (347)
Immuno-oncology (105)
Indications (195)
Infectious disease (3405)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (300)
Interviews (820)
IPO (17992)
IRA (61)
Job creations (5206)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (113)
Layoffs (680)
Leadership (50)
Legal (10171)
Liver cancer (108)
Longevity (35)
Lung cancer (811)
Lymphoma (440)
Machine learning (64)
Management (66)
Manufacturing (1155)
MASH (206)
Medical device (15234)
Medtech (15362)
Mergers & acquisitions (23222)
Metabolic disorders (1699)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (474)
Neuropsychiatric disorders (125)
Neuroscience (3602)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (79)
Obesity (823)
Opinion (368)
Ovarian cancer (229)
Pain (275)
Pancreatic cancer (316)
Parkinson's disease (390)
Partnered (39)
Patents (626)
Patient recruitment (702)
Peanut (67)
People (67777)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24254)
Phase 2 (34101)
Phase 3 (25644)
Pipeline (8981)
Policy (387)
Postmarket research (3558)
Preclinical (10926)
Press Release (72)
Prostate cancer (321)
Psychedelics (68)
Radiopharmaceuticals (353)
Rare diseases (1205)
Real estate (7458)
Recruiting (81)
Regulatory (30121)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (315)
Series B (228)
Service/supplier (30)
Sickle cell disease (122)
Special edition (31)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4365)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (140)
Vaccines (1267)
Venture capital (124)
Weight loss (568)
Women's health (132)
Worklife (24)
Date
Today (64)
Last 7 days (926)
Last 30 days (3617)
Last 365 days (32924)
2026 (13522)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (391)
Arkansas (16)
Asia (52105)
Australia (9166)
California (13837)
Canada (3883)
China (1455)
Colorado (596)
Connecticut (614)
Delaware (424)
Europe (120141)
Florida (2049)
Georgia (451)
Hawaii (4)
Idaho (69)
Illinois (1179)
India (99)
Indiana (640)
Iowa (25)
Japan (558)
Kansas (141)
Kentucky (56)
Louisiana (46)
Maine (89)
Maryland (1690)
Massachusetts (10101)
Michigan (413)
Minnesota (770)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (149)
New Hampshire (92)
New Jersey (3684)
New Mexico (34)
New York (3633)
North Carolina (1876)
North Dakota (11)
Northern California (6834)
Ohio (430)
Oklahoma (26)
Oregon (55)
Pennsylvania (2749)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5414)
Tennessee (218)
Texas (2244)
United States (49563)
Utah (413)
Vermont (1)
Virginia (359)
Washington D.C. (88)
Washington State (1142)
West Virginia (4)
Wisconsin (153)
Wyoming (2)
There are 881,173 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensorion Appoints Fred Chereau as Chief Executive Officer
May 18, 2026
·
6 min read
Press Releases
Cytovation to Evaluate Getacatetide (CY-101) in Combination with Checkpoint Inhibitor Tislelizumab in Colorectal Cancer
May 18, 2026
·
3 min read
Press Releases
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
May 18, 2026
·
2 min read
Press Releases
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
May 18, 2026
·
8 min read
Press Releases
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
May 18, 2026
·
5 min read
Press Releases
Ipsen initiates a new share buy-back program - May 18, 2026
May 18, 2026
·
5 min read
Press Releases
NovalGen Appoints Dr Laurent Fischer as Chair of the Board
May 18, 2026
·
2 min read
Press Releases
LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
May 18, 2026
·
2 min read
Press Releases
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
May 18, 2026
·
7 min read
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
1 of 88,118
Next
